Impact of Staphylococcus Aureus on Folliculitis Decalvans
NCT02157688 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2016-06-24
Summary
The folliculitis decalvans (FD) is an orphan disease , common in consultation specialized on scalp. This disease is currently not curable, responsible for significant for patients. The pathophysiology is poorly understood, Staphylococcus aureus (SA) appears to play a role, never previously studied, and the study will attempt to clarify it.
Controversies in the literature on the pathophysiological hypotheses can be summed up as follows :
FD is it an infectious folliculitis where SA (almost always found on the lesions plays a direct role possibly aided by a lack of local immune protection , or is it a pustular inflammatory unknown cause where the SA has no direct role but is a cofactor or a simple germ superinfection.
Our study has plans to bring new evidence to help decide between these two opposite but not mutually exclusive concepts .
Conditions
- Folliculitis Decalvans
- Staphylococcus Aureus
Interventions
- OTHER
-
no intervention : case control study
Sponsors & Collaborators
-
Assistance Publique - Hôpitaux de Paris
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2014-03-31
- Primary Completion
- 2015-03-31
- Completion
- 2015-03-31
Countries
- France
Study Locations
More Related Trials
-
A Non-interventional Study to Describe the Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
NCT06087627 ·Status: RECRUITING
-
People of Color and Dermatology: A Deeper Look at Patients' Perceptions of Care and the Need for Greater Diversity in Dermatology
NCT04991285 ·Status: COMPLETED
-
Clinical Characteristics of Pruritus and Evaluation of Quality of Life in Patients With Bullous Pemphigoid
NCT03272958 ·Status: COMPLETED
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
The Ohio State University Dermatology Biorepository
NCT03146676 ·Status: RECRUITING
-
Vitiligo Treatment by Targeting TYK2 Mediated Responses
NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Defects of Keratinocytes Function in Dermatologic Patients
NCT06324552 ·Status: RECRUITING
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Characterization of Bacterial and Mycosis Skin Flora in Seborrheic Macular Hypopigmentation - Microbiome
NCT06908889 ·Status: RECRUITING ·Phase: NA
-
Trichoscopy and Systemic Scleroderma
NCT04804930 ·Status: RECRUITING
-
Determinants of Chronic Inflammatory Skin Disease Trajectories
NCT05928169 ·Status: RECRUITING
-
Identification of Vulnerability Factors in the Course of Pemphigus Patients
NCT02237313 ·Status: COMPLETED ·Phase: NA
-
Ruxolitinib in Seborrheic Dermatitis
NCT05787860 ·Status: COMPLETED ·Phase: PHASE2
-
Activation of a Cutaneous Inflammasome in the Skin of Hidradenitis Suppurativa Patients
NCT02833909 ·Status: COMPLETED ·Phase: NA
-
Physiopathological Study and Pharmacological Modulation of Cutaneous Atrophy's Markers Induced by Glucocorticoids
NCT00709579 ·Status: UNKNOWN ·Phase: PHASE3
-
Fresolimumab In Systemic Sclerosis
NCT01284322 ·Status: COMPLETED ·Phase: PHASE1
-
Pathophysiological Study of the Sensitive Scalp
NCT07156422 ·Status: RECRUITING ·Phase: NA
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo
NCT06319781 ·Status: RECRUITING
-
T Cell Repertoire Analysis of Immune Mediated Skin Diseases
NCT00368784 ·Status: COMPLETED
-
Study of Scaling Disorders and Other Inherited Skin Diseases
NCT00001292 ·Status: COMPLETED
-
Rationalization of the Treatment Pathway of Patient Suffering From Rare Skin Disease With Telemedicine
NCT02465476 ·Status: COMPLETED ·Phase: NA
-
Characterization of the Cytokine Profile and the Microbiome in Darier's Disease
NCT06614777 ·Status: RECRUITING ·Phase: NA
-
Interest of a Systematic Biopsy for Hard-to-heal Leg Ulcers
NCT00709631 ·Status: COMPLETED
-
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome.
NCT04904146 ·Status: RECRUITING